By Davide Smaldone
As more pharmaceutical and biopharmaceutical companies start their Pharma 4.0 journey, many are struggling to find an effective approach that could both suit the needs of the organization and bring value to the final users. There are several alternatives for shaping a Pharma 4.0 program, and choosing among them is usually a very complex exercise. There is no one-size-fits-all solution. In fact, the answer to the question, “Where can my company start a Pharma 4.0 initiative?” depends upon a company’s size, culture, system landscape, level of integration, propensity for risk, management attitude toward innovation, and much more.